New England Peptide of Gardner has joined with other companies whose work relates to the biological functions of proteins to form a new industry organization, Proteomics Innovation Network.
The network has 13 member companies that work in biomarker and drug target discovery, personalized medicine, drug profiling and selective reaction monitoring. New England Peptide said the group is intended to encourage collaboration to move research forward.
